Five weeks after launch, the Wegovy pill is named by nearly as many UK providers as the injectable
August 2026 / Obesity / UK
More analyses
The NHS community weight-management list is ageing, not clearing
June 2026 / Obesity / UK
Obesity in England, where the burden falls
June 2026 / Obesity / UK
Brand analysis: UK pharmacy obesity treatments, June 2026
June 2026 / Obesity / UK
About this market
Weight management provision spans prescribed medicines, bariatric surgery and behavioural programmes rather than one kind of service. Across all approved UK locations, Rare.Monitor records weight management provision at 5,641 locations, linked to 680 distinct owner records, on figures read on 20 August 2026. Rare.Monitor records private provision only, so NHS weight management services are not counted in that figure.
FAQ
Frequently asked questions
Questions answered from Rare.Monitor data, figures read 20 August 2026.
How many UK locations offer weight management treatment?
Rare.Monitor records weight management provision at 5,641 approved UK locations. That figure counts all three kinds of provision in the classification: prescribed weight-loss medicines, bariatric surgery, and behavioural programmes. The tag is detected from what each location publishes about its own treatments, so the count records provision rather than measuring the whole market. Source: Rare.Monitor, figures read 20 August 2026.What counts as weight management provision in Rare.Monitor data?
Weight management in Rare.Monitor covers three kinds of provision recorded from a location's own published text: medicated weight management, where a prescribed weight-loss medicine is named; bariatric surgery, including gastric bypass, sleeve gastrectomy and gastric balloons; and behavioural weight management programmes. This hub's figure counts all three. Source: Rare.Monitor.How is UK weight management provision structured by ownership?
Rare.Monitor links the 5,641 approved UK locations recording weight management provision to 680 distinct owner records. Rare.Monitor counts distinct owner records rather than how many locations each owner holds, so these figures do not show how concentrated ownership is or how many providers operate from a single site. Locations approved most recently have not yet been matched to an owner record, so 680 counts the owners matched so far rather than every owner behind these locations. Source: Rare.Monitor, figures read 20 August 2026.What does Rare.Monitor track in the obesity treatment segment?
Rare.Monitor tracks treatment classifications, brand mentions and ownership links across more than 230,000 reportable locations in the United Kingdom and Republic of Ireland (ROI). For obesity treatment that covers which weight-loss treatments each UK location publishes, which medicine brands it names, and which organisation owns it. Records are built from what each location publishes, so figures are restated on each new market read. Source: Rare.Monitor, platform figures read 4 August 2026.When were the weight management locations on this page approved into the dataset?
The 5,641 UK weight management locations on this page were approved into the Rare.Monitor dataset between February and August 2026. Approval is the point at which a location's record passes review and enters the reportable set. Classification passes then run in a rolling nine to ten week window, so a location's treatment detail can be refreshed after its approval date. Source: Rare.Monitor, figures read 20 August 2026.
Methodology: Rare.Monitor is a private-market dataset, built on what each location publishes about its own treatments rather than on an official market survey, so a count records provision rather than measuring the whole market. Market figures on this page were read on 20 August 2026, in one read. Rare.Monitor records weight management provision at 5,641 approved UK locations, linked to 680 distinct owner records over the same locations in the same read. Weight management covers three kinds of provision: medicated weight management, where a prescribed weight-loss medicine is named; bariatric surgery; and behavioural weight management programmes. All three are counted in the figure above. Locations in this cohort were approved into the dataset between February and August 2026. Rare.Monitor counts distinct owner records rather than how many locations each owner holds, so they support no statement about how concentrated ownership is. Provider matching runs as a later stage, so locations approved most recently are not yet matched to an owner record, and the count covers the owners matched so far rather than every owner behind these locations. The classification is detected from website text rather than confirmed by a regulator, so a count carries some records the detection has placed wrongly. Most records have not yet had a full treatment re-scrape, so the count records the locations detected so far rather than every UK location offering these treatments. Classification passes for the cohort fall in a rolling nine to ten week window rather than on one fixed collection date. Platform-wide figures were read separately on 4 August 2026 and are not comparable with the market figures above. Figures in the linked analyses below come from earlier snapshots measured on their own bases, so they are not a trend series with the figures on this page. Source: Rare.Monitor.